Western blot analysis revealed that AD mice exhibited a significant upregulation of APP and P‐Tau expression in the cortex and hippocampus, while these expression levels were significantly decreased in the myricetin treated AD mice (Figure 4C,D). This evidence concerns the gene MAPT and Alzheimer disease.